{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T08:02:36Z","timestamp":1791619356778,"version":"4.3.4"},"reference-count":40,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2013,2,19]],"date-time":"2013-02-19T00:00:00Z","timestamp":1361232000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal Orthopaedic Research"],"published-print":{"date-parts":[[2013,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:label\/><jats:p>A case\u2013control study was conducted to estimate the association of cartilage oligomeric matrix protein (COMP) with knee osteoarthritis (OA) and to examine the potential utility of COMP as a diagnostic and prognostic biomarker in early knee OA. The COMP levels were estimated in the blood sera of 150 subjects belonging to study group (<jats:italic>n<\/jats:italic>\u2009=\u2009100) and control one (<jats:italic>n<\/jats:italic>\u2009=\u200950). Patients with confirmed clinical isolated knee OA diagnosed through American College of Rheumatology criteria were included and were without any other cause of knee pain. ELISA was used to determine the levels of COMP, interleukin\u20101\u03b2 (IL\u20101\u03b2) and tumor necrosis factor\u2010\u03b1 (TNF\u2010\u03b1). The median (range) serum COMP levels were observed to be 1117.21\u2009ng\/ml (125.03\u20134209.75\u2009ng\/ml) in OA patients and 338.62\u2009ng\/ml (118\u2013589\u2009ng\/ml) in control subjects with <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001. The COMP levels of study group were negatively correlated (correlation factor \u22120.88) with disease duration and positively correlated with age, BMI, pain score and IL\u20101\u03b2 with correlation factors 0.86, 0.63, 0.76, and 0.79, respectively with <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001. Gender differentiation was found in study group with 52% higher COMP level in males as compared to that of females. There was no significant correlation of COMP levels with radiological grading, erythrocyte sedimentation rate (ESR), hemoglobin (Hb), and TNF\u2010\u03b1. The serum COMP levels may be used as a diagnostic OA marker along with prognostic value in determining the patients at risk of rapidly progressing this debilitating joint disease. The serum COMP level remains significantly high in first 3 years of disease duration. \u00a9 2013 Orthopaedic Research Society Published by Wiley Periodicals, Inc. J Orthop Res 31:999\u20131006, 2013<\/jats:p><\/jats:sec>","DOI":"10.1002\/jor.22324","type":"journal-article","created":{"date-parts":[[2013,2,19]],"date-time":"2013-02-19T22:54:27Z","timestamp":1361314467000},"page":"999-1006","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":138,"title":["Serum cartilage oligomeric matrix protein (COMP) in knee osteoarthritis: A novel diagnostic and prognostic biomarker"],"prefix":"10.1002","volume":"31","author":[{"given":"Priyanka","family":"Verma","sequence":"first","affiliation":[{"name":"Department of Biophysics All India Institute of Medical Sciences New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna","family":"Dalal","sequence":"additional","affiliation":[{"name":"Department of Biophysics All India Institute of Medical Sciences New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,2,19]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780290816"},{"key":"e_1_2_7_3_1","first-page":"751","article-title":"The biomarker assay for cartilage destruction in rheumatoid arthritis\u2014which molecules can reflect cartilage breakdown in RA","volume":"13","author":"Ishiguro N","year":"2003","journal-title":"Clin Calcium"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.csm.2004.08.007"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10586"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-000-0021-y"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1063-4584(97)80008-8"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.blo.0000144854.66565.8f"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm763"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113823"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.2460\/ajvr.2000.61.624"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.22203\/eCM.v012a06"},{"key":"e_1_2_7_13_1","first-page":"21","article-title":"Molecular markers of processes in cartilage in joint disease","volume":"30","author":"Heineg\u00e5rd D","year":"1991","journal-title":"Br J Rheumatol"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-9120(92)90250-V"},{"key":"e_1_2_7_15_1","first-page":"461","article-title":"Serum keratan sulfate concentration as a measure of the catabolism of cartilage proteoglycans","volume":"30","author":"Thonar EJ.","year":"1990","journal-title":"Ryumachi"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2011.09.012"},{"key":"e_1_2_7_17_1","first-page":"171","article-title":"Aggrecan and cartilage oligomeric matrix protein in serum and synovial fluid of patients with knee osteoarthritis","volume":"6","author":"El\u2010Arman MM","year":"2010","journal-title":"Hosp Spec Surg J"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199806)41:6<997::AID-ART6>3.0.CO;2-G"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2344"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199911)42:11<2356::AID-ANR14>3.0.CO;2-R"},{"key":"e_1_2_7_21_1","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.1016\/S0021-9258(18)42672-5","article-title":"Electron microscopy of native cartilage oligomeric matrix protein purified from the Swarm rat chondrosarcoma reveals a five\u2010armed structure","volume":"267","author":"M\u00f6rgelin M","year":"1992","journal-title":"J Biol Chem"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)42671-3"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/jor.1100130316"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/31.9.583"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/31.9.593"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117753"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/34.4.306"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/37.1.46"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.16.4.494"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.32.20397"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M009507200"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M705735200"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780360105"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.53.1.8"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200006)43:6<1425::AID-ANR33>3.0.CO;2-X"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10822"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199901)42:1<17::AID-ANR2>3.0.CO;2-E"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20776"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.2741\/1817"},{"key":"e_1_2_7_40_1","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.4049\/jimmunol.163.9.5049","article-title":"IL\u20101 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen\u2010induced arthritis, whereas TNF\u2010alpha blockade only ameliorates joint inflammation","volume":"163","author":"Joosten LA","year":"1999","journal-title":"J Immunol"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.56.5.299"}],"container-title":["Journal of Orthopaedic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjor.22324","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jor.22324","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T04:32:05Z","timestamp":1698640325000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jor.22324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,19]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["10.1002\/jor.22324"],"URL":"https:\/\/doi.org\/10.1002\/jor.22324","archive":["Portico"],"relation":{},"ISSN":["0736-0266","1554-527X"],"issn-type":[{"value":"0736-0266","type":"print"},{"value":"1554-527X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,19]]},"assertion":[{"value":"2012-10-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-01-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-02-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}